Previous 10 | Next 10 |
Gainers: Alterity Therapeutics (ATHE) +120%, Outset Medical (OM) +17%, Keros Therapeutics (KROS) +9%, Inovio Pharmaceuticals (INO) +10%, Fulgent Genetics (FLGT) +14%.Losers: RAPT Therapeutics (RAPT) -46%, IMAC Holdings (IMAC) -10%, BioNTech (B...
Alterity Therapeutics soars ([[ATHE]] +135.7%) after it has collared US patent for its next generation compounds that are designed to assist in treating Parkinson’s and Alzheimer’s as well as other neurodegenerative conditions.The patent covers more than 150 novel pharmaceutical...
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases PR Newswire MELBOURNE, Australia, Nov. 16, 2020 MELBOURNE, Australia , Nov. 16, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("A...
Alterity Therapeutics (ATHE) +117%.HighPoint Resources (HPR) +98%.CBAK Energy Technology (CBAT) +27%.HD Supply Holdings (HDS +24% after announcing agreement to be acquired by HD.voxeljet AG (VJET) +23%.Maiden Holdings (MHLD) +19%.Banco Bilbao Vizcaya Argentaria, S.A. (BBVA +19%...
Alterity Therapeutics ([[ATHE]] -2.5%) commenced patient enrollment in its bioMUSE study, for Multiple System Atrophy ((MSA)). BioMUSE is a natural history study that aims to track the progression of patients with MSA.The study is enrolling early stage MSA patients and will track changes...
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study PR Newswire MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NA...
Gainers: ReWalk Robotics (RWLK) +18%, Aldeyra Therapeutics (ALDX) +19%, ClearPoint Neuro (CLPT) +15%, ProPhase Labs (PRPH) +12%, Orchard Therapeutics (ORTX) +11%.Losers: Biomerica (BMRA) -20%, Adaptimmune Therapeutics (ADAP) -14%, Ca...
Gainers : IMAC Holdings (NASDAQ: IMAC ) +59% . More news on: IMAC Holdings, Inc., MYOS RENS Technology Inc., Marathon Patent Group, Inc., Stocks on the move, Read more ...
Vapotherm (NYSE: VAPO ) -26% on Q2 earnings . More news on: Vapotherm, Inc., New Relic, Inc., Alterity Therapeutics Limited, Stocks on the move, , Read more ...
Gainers: Alterity Therapeutics (NASDAQ: ATHE ) +210% . More news on: Alterity Therapeutics Limited, SilverSun Technologies, Inc., Universal Security Instruments, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Alterity Therapeutics Limited Company Name:
ATHE Stock Symbol:
NYSE Market:
Alterity Therapeutics Limited Website:
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today an...